Competing interests: Dr. Kassouf has received grants/honoraria from Astellas, AstraZeneca, Janssen, Merck, and Roche. Dr. Fairey has been a speaker for J&J and Roche. Dr. Finelli has attended advisory boards for AbbVie, Amgen, Astellas, Bayer, Janssen, Roche, and Sanofi. Dr. Kapoor has attended advisory boards for and participated in clinical trials supported by Amgen, Astellas, GSK, Janssen, Novartis, Pfizer, and Sanofi. Dr. Lattouf has attended advisory boards AbbVie, Amgen, Astellas, Novartis, and Pfizer; and has received an educational grant from Janssen. Dr. Leveridge has attended advisory boards for Astellas. Dr. Power has participated in clinical trials supported by Argos Therapeutics. Dr. Pouliot has attended advisory boards for, Amgen, Astellas, and Pfizer; has been a speaker for Sanofi; has received payment/grants/honoraria from Amgen, Astellas, Astra Zeneca, Janssen, Pfizer, and Sanofi. Dr. So has been a speaker for Amgen, Astellas, and Janssen. Dr. Tanguay has attended advisory boards for Pfizer; and has received travel grants from Sanofi. The remaining authors report no competing personal or financial interests.